(lp0
S'Rexahn Pharmaceuticals Inc  Continues To Shine Against A Backdrop ... Insider Financial - 15 hours ago Early March, we said that readers should keep an eye on Rexahn Pharmaceuticals, Inc.  as 2017 matures. The company had basically run flat throughout January, and then took a little jump during February.Analytical Guide for Rexahn Pharmaceuticals, Inc. , Trevena, Inc. (TRVN ... - The USA CommerceRexahn Pharmaceuticals, Inc.  hit its 52 Week high of $0.56 - The Newburgh Press'
p1
aS'BioDelivery Sciences International and Rexahn Pharmaceuticals See Share Values ... Yahoo Finance - 17 hours ago Rexahn Pharmaceuticals advanced 13.33% to close at $0.51 on Monday. The stock traded between $0.52 and $0.44 per share on volume of 7,032,752 shares traded.'
p2
aS'All You Need To Know About Rexahn Pharmaceuticals, Inc.  Revealed ... NY Stock News - 17 hours ago The technicals for Rexahn Pharmaceuticals, Inc.  have taken shape, and with them a comprehensive picture has emerged.'
p3
aS'Keep An Eye On Rexahn Pharmaceuticals Inc  This Year Insider Financial - Mar 13, 2017 Rexahn Pharmaceuticals, Inc.  ran up towards the end of last week on basically no news, and is running again early session in the US on Monday.The Epic Rise of Rexahn Pharmaceuticals, Inc.  - The Oracle DispatchWhy to Keeping Eye on JC Penney Company, Inc. , Rexahn Pharmaceuticals ... - StockNewsJournal'
p4
aS'Rexahn Pharmaceuticals, Inc. : Getting Technical With The Stock USA Commerce Daily - 12 hours ago With all other things going on, Rexahn Pharmaceuticals, Inc.  has been on a run - rising 239.32 percent in just three months.'
p5
aS"Rexahn Pharmaceuticals, Inc.  Announces Full Year 2016 Financial Results Smarter Analyst - Feb 27, 2017 Rexahn Pharmaceuticals, Inc.  announced financial results for the year ended December 31, 2016 and provided an update on the Company's clinical development programs.Trading updates about Stock: Rexahn Pharmaceuticals, Inc.  - Is stories"
p6
aS'Rexahn Pharmaceuticals  Jumps: Stock Moves Up 5.4% Yahoo Finance - Mar 16, 2017 Rexahn Pharmaceuticals, Inc. RNN was a big mover last session, as its shares rose above 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session.'
p7
aS'An End-of-Day Technical Review: Rexahn Pharmaceuticals, Inc. , Freeport ... Post Analyst - Mar 27, 2017 Rexahn Pharmaceuticals, Inc. has a consensus buy rating from 2 Wall Street analysts, and the number of shares currently sold short amount to at least 4.59% of shares outstanding.'
p8
aS'Earnings Clues on Rexahn Pharmaceuticals, Inc. , CYS Investments, Inc ... StockNewsJournal - Mar 23, 2017 ROI deals with the invested cash in the company and the return the investor realize on that money based on the net profit of the business.Rexahn Pharmaceuticals, Inc. subtracted -8.98% in its Stock Price in the ... - Free ObserverIn Good Financial Health?  Rexahn Pharmaceuticals, Inc. , The Medicines ... - USA Commerce Daily'
p9
aS"Worth Watching Stocks: ZIOPHARM Oncology, Inc. , Rexahn Pharmaceuticals ... TRA - 18 hours ago ZIOPHARM Oncology, Inc.  ended its previous trading session at $6.69 with the Gain of 13.78%. The company's market cap is $777.1 Million, and the average volume is $1.43 Million. The 52-Week High range of the stock is $9.19, while the 52-week low&nbsp;..."
p10
a.